Business Wire

YuppTV Awarded Rights for Vivo-IPL 2018 for Australia, Continental Europe and South East Asia

Jaa

As the most awaited event of the year, the Vivo-IPL 2018, which is Season 11 of the world’s biggest T20 tournament, approaches, cricket fans have yet another reason to rejoice! YuppTV, the world’s leading OTT brand for South-Asian content, has announced that it has awarded the exclusive digital & television media rights for Vivo-IPL 2018 by Star India for Europe, South America, South East Asian countries, and non-exclusive rights for Australia.

Scheduled to take place from 7 April to 27 May 2018, the Vivo-IPL 2018, the biggest and most eagerly awaited cricketing extravaganza in a decade of IPL history, will witness eight teams playing this season including Chennai Super Kings and Rajasthan Royals that are back in action after serving two years of suspension. With the enormous anticipation and such high stakes in the offing and an exciting line-up of teams, cricket fans the world over have the perfect window to catch every swing and ball of the Vivo-IPL 2018, thanks to the YuppTV app.

Commenting on the announcement, Mr. Uday Reddy, Founder & CEO, YuppTV, said, “By bagging the exclusive digital media rights for the Vivo-IPL 2018, we are enabling live, on-the-go access to the cricket tournament for our users. Our endeavor is to provide them with seamless, real-time access to all the matches and allow our viewers from across different geographical boundaries to watch their favorite teams in action on their preferred device!”

Cricket lovers in Europe, South America, South East Asian countries and Australia can catch all the action from the Vivo-IPL 2018 on YuppTV www.yupptv.com or via the YuppTV app on their smart TVs, smart Blu-ray players, streaming media players, gaming consoles, smartphones, and tablets.

About YuppTV:

YuppTV is one of the world’s largest internet-based TV and On-demand service provider for South Asian content, offering more than 300+ TV channels, 5000+ Movies and 100+ TV Shows in 14 languages. YuppTV, received funding from Emerald Media, a Pan-Asian platform established by leading global investment firm KKR for investing in the media and entertainment sector, wherein Emerald Media acquired a significant minority stake in the company for US$50mn. Emerald Media is led by industry veterans Rajesh Kamat and Paul Aiello, supported by an experienced team of investment and operating executives. The platform primarily focuses on providing growth capital to media, entertainment and digital media companies. YuppTV had earlier raised its Series A round of funding from Poarch Creek Indian Tribe of Alabama.

YuppTV has 25000 hours of entertainment content catalogued in its library, while nearly 2500 hours of new on-demand content (including catch up content) is added to the YuppTV platform every day. It also offers YuppFlix, a movie on demand streaming service for Expat Market and has recently launched YuppTV Originals to bring forth unconventional story telling in collaboration with the top talent from the movie industry. YuppTV is currently ranked #1 Internet Pay TV platform for Indians living abroad and the largest Internet TV platform from premium content availability in India. YuppTV is the most downloaded Indian SmartTV app, and it also boasts of 14.5 million mobile downloads with 4.0 user rating.

Contact information

YuppTV
Shivam Agarwal, shivam@yupptv.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Vertex Announces Long-Term Access Agreement in Sweden for Cystic Fibrosis Medicine ORKAMBI® (lumacaftor/ivacaftor)18.6.2018 14:00Tiedote

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that ORKAMBI® (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis (CF) in people with two copies of the F508del mutation, ages six and older, will be reimbursed in Sweden after concluding the three-party negotiations with TLV and the county councils. Reimbursement is effective from July 1. The innovative, long-term access agreement also provides a framework for the assessment and access of our future CF medicines. “We are delighted that people with CF in Sweden will join the thousands of others around the world who are already benefitting from our CF medicines,” said Simon Bedson, International General Manager at Vertex. “We commend the Swedish authorities for partnering with us on an innovative, long-term access agreement. In countries where Vertex remains actively involved in reimbursement discussions, we encourage these health authorities and governments to match the commitment

LG Chem Hosts Global Innovation Contest 2018 (GIC 2018)"Finding Innovations to Change the World"18.6.2018 14:00Tiedote

LG Chem (KRX: 051910) is exploring innovative technologies that will change the world. LG Chem announced that it would hold a Global Innovation Contest (GIC) for leading universities and research institutions around the world. This is the first time that a Korean chemical company is conducting technology contests for the entire world. From June 18th to September 30th, 2018, LG Chem will accept innovative technology ideas in five promising business areas: Energy, Environment, Functional materials, Bio technology and Platform technology. Global scholars and researchers who are interested in developing the next generation’s innovative technology and industry-academia collaboration research are welcomed to participate and submit the technical proposal through the official website (www.rnd.lgchem.com/global/gic). LG Chem will select internal experts and selection committees to evaluate the proposals considering technology innovation, marketability, and price competitiveness. Selected assign

Octapharma announces approval of new Nuwiq® product strengths in Europe, increasing dosing flexibility for patients with haemophilia A18.6.2018 10:06Tiedote

Octapharma announced today that the European Medicines Agency (EMA) has approved an extension of marketing authorisation for its human cell line-derived recombinant factor VIII (rFVIII) product, Nuwiq®. New single dose vial strengths of 2500, 3000 and 4000 International Units (IU) will be available in Europe, in addition to the current strengths of 250, 500, 1000 and 2000 IU. The new Nuwiq® vial strengths have been available in the US since September last year, following approval by the FDA. Nuwiq® is indicated in adults and children of all ages for on-demand treatment and prophylaxis, including during surgery, to prevent and control bleeding episodes in patients with haemophilia A. This expanded array of vial strengths has the potential to increase treatment options for patients with haemophilia A by improving dosing flexibility. Patients who previously required more than one vial per infusion may be able to reduce the number of vials needed. Nuwiq® is the only rFVIII available in an

STATS and SpokeHub Partner to Power Deeper, More Meaningful Conversations Around the 2018 FIFA World Cup18.6.2018 10:00Tiedote

Today, STATS, the worldwide leader in sports data and intelligence, and SpokeHub announced a new partnership to bring STATS Insights to SpokeHub’s social engagement platform, connecting worldwide World Cup football (soccer) fans with content that is more impactful. Download the app today to see the match scores, player insights, and engage with World Cup fans everywhere! STATS Insights leverages more than 37 years of research experience to deliver deep historical and comparative statistical insights, play-by-play descriptions and in-game trends based on events as they happen in the match. Before, during and after each match, SpokeHub will harness STATS Insights to amplify conversations among World Cup football communities. During the game, live Insights will deliver trends on players and teams based on in-game events, statistics and milestones. “No sporting event gets global attention like the World Cup, and every fan is looking for deeper analysis around their favorite teams and playe

Celltrion Completes Resubmission to FDA for Proposed Trastuzumab Biosimilar18.6.2018 05:53Tiedote

Celltrion (KRX:068270) has made a resubmission to the FDA (U.S. Food and Drug Administration) to obtain its marketing approval for CT-P6, a proposed mAb biosimilar to Herceptin® (trastuzumab). Celltrion submitted its abbreviated Biologics License Applications (aBLAs) for CT-P10 and CT-P6 to the FDA in April and May of last year, respectively. However, it received CRLs (complete response letters) from the FDA related to the warning letter issued by the FDA in January 2018, related to the manufacturing facility in Incheon, South Korea. Celltrion had completed the resubmission for the approval of CT-P10, a proposed biosimilar to Rituxan® (rituximab) last month. In accordance with FDA regulations, the approval procedure will be usually finalized within six months from the resubmission, so Celltrion expects the approval for the U.S. market of the two proposed biosimilars within this calendar year. FDA has notified Celltrion of its re-inspection schedule regarding regular audit results, and

CES Asia: Innovation at the Speed of 5G15.6.2018 17:59Tiedote

CES Asia® 2018 wrapped today with the rapid pace of global innovation front and center over the show’s three day duration. The next stage of technology advancements were showcased across vehicle tech, robotics, artificial intelligence (AI), virtual and augmented reality, digital health and more. The event, 24 percent larger than last year in terms of footprint, cemented itself as the place to fully experience how the pace of technology is accelerating globally. CES Asia, the premier event for tech innovation in the Asian marketplace, will return to Shanghai, China, June 11-13, 2019. “5G and AI are igniting growth across the entire tech ecosystem changing the way we interact with technology and the world around us,” said Gary Shapiro, president and CEO, Consumer Technology Association (CTA)™. “It’s incredible to see technology refining and reinventing itself at such a fast pace. Just six months ago we were at CES with life-altering tech all around us. This week, I saw that technology re

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme